window.globalProvideData('caption', '{"data":"WEBVTT%0D%0AKind:%20captions%0D%0ASource:%20Articulate%20Closed%20Captions%20Editor%0D%0ASource%20Version:%206.20.16814.0%0D%0A%0D%0A00:00:00.150%20--%3E%2000:00:04.994%0D%0AThe%20NIH%20Guidelines%20for%20Research%20Involving%20Recombinant%20or%20Synthetic%20Nucleic%20%0D%0A%0D%0A00:00:05.000%20--%3E%2000:00:09.324%0D%0AAcid%20Molecules,%20hereafter%20referred%20to%20as%20the%20NIH%20Guidelines,%20%0D%0A%0D%0A00:00:09.510%20--%3E%2000:00:14.487%0D%0Ais%20administered%20by%20the%20NIH%20Office%20of%20Science%20Policy%20(OSP).%20%0D%0A%0D%0A00:00:15.273%20--%3E%2000:00:20.413%0D%0AThe%20scope%20of%20this%20federal%20agency%20is%20to%20promote%20progress%20in%20the%20biomedical%20research%20%0D%0A%0D%0A00:00:20.431%20--%3E%2000:00:25.458%0D%0Aenterprise%20through%20the%20development%20of%20sound%20and%20comprehensive%20policies.%0D%0A%0D%0A00:00:25.740%20--%3E%2000:00:32.353%0D%0AThe%20OSP%20%20is%20the%20primary%20policy%20adviser%20to%20the%20NIH%20Director%20on%20matters%20of%20significance%20%0D%0A%0D%0A00:00:32.354%20--%3E%2000:00:37.235%0D%0Ato%20the%20agency,%20the%20research%20community,%20and%20the%20public.%20%0D%0A%0D%0A00:00:37.253%20--%3E%2000:00:41.624%0D%0AIn%20the%20next%20few%20slides,%20we%20will%20discuss%20the%20scope%20of%20the%20NIH%20Guidelines%20and%20%0D%0A%0D%0A00:00:41.654%20--%3E%2000:00:43.291%0D%0Athe%20research%20that%20is%20covered.%0D%0A%0D%0A"}')